Loading clinical trials...
Loading clinical trials...
IImpact of Hyperuricemia on Psoriatic Arthritis
Psoriatic arthritis and gout (linked to hyperuricemia) are two rheumatisms well known to rheumatologists. There are epidemiological and physiopathological arguments in favor of a non-fortuitous link between these two rheumatisms, which to date has not been established. There is currently no recommendation to treat hyperuricaemia without an episode of gout attack. We hypothesize that there is a link between hyperuricemia and severity of rheumatism. This would ultimately modify the therapeutic management of hyperuricemic patients followed for psoriatic arthritis.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Service de Rhumatologie - CHU de Strasbourg - France
Strasbourg, France
Start Date
August 24, 2020
Primary Completion Date
December 1, 2023
Completion Date
December 31, 2023
Last Updated
December 8, 2023
242
ESTIMATED participants
Lead Sponsor
University Hospital, Strasbourg, France
NCT07295509
NCT06100744
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04402086